Product Specifications Compound: BPC-157 (Body Protection Compound 157) Amount: 10mg per vial Purity: 99% (HPLC-verified) Form: Lyophilized powder Storage: Keep refrigerated at 28C Shipping: 25 business days Use: Research and laboratory use only Frequently Asked Questions What is BPC-157 10mg used for in research
One of the first facial creams to target the effects of GLP-1s on the skin, the cream focuses on what founder, plastic surgeon Marc Ronert, describes as the '4 Ds' of 'Ozempic face': deflation, density loss, deep wrinkles, and dehydration
As featured in Ozempic is FDA-approved brand-name semaglutide from Novo Nordisk the medication that started the GLP-1 revolution, prescribed by licensed providers only when medically appropriate
This combination of amino acid and antioxidant presents a compelling case for exploration
The study is by Dr Daniel Weghuber, Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria, and Dr Rasmus Srrig, Novo Nordisk A/S (the manufacturer of semaglutide), Sborg, Denmark, and colleagues
[PMC free article: PMC5215680] [PubMed: 28054644] [CrossRef] 134